Evidence map›Paper›PMID 16678874›Full record

ArticleVirology2006

Core labeling of adenovirus with EGFP.

Long P Le, Helen N Le, Amy R Nelson, David A Matthews, Masato Yamamoto, David T Curiel

Open access · greenAbstract read
In one paragraph

Article in Virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Current issues and future directions of oncolytic adenoviruses.Molecular therapy : the journal of the American Society of Gene Therapy · 2010
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Long P LeDivision of Human Gene Therapy, Departments of Medicine, Pathology and Surgery, University of Alabama at Birmingham, 901 19th Street South, BMR2-502, Birmingham, AL 35294, USA.
Helen N Le
Amy R Nelson
David A Matthews
Masato Yamamoto
David T Curiel
University of Alabama at Birmingham · USUniversity of Bristol · GB

Funding

Virus adjunctive therapies for pancreatic cancerP20CA101955 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BUCHSBAUM, DONALD J. · 2003 to 2007
$4.6M
Enhanced CRAd for Pancreatic CancerR01CA094084 · NCI · UNIVERSITY OF MINNESOTA · PI YAMAMOTO, MASATO · 2002 to 2013
$2.7M
REPLICATIVE ADENOVIRUSES WITH ENHANCED INFECTIVITYR01CA083821 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURIEL, DAVID TERRY · 2000 to 2008
$1.9M
Enhanced CRAd for Esophageal AdenocarcinomaR01DK063615 · NIDDK · UNIVERSITY OF MINNESOTA · PI YAMAMOTO, MASATO · 2003 to 2007
$1.7M
Capsid-labeled adenovirus for virotherapy monitoringR01CA111569 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURIEL, DAVID TERRY · 2005 to 2009
$1.5M
NCI NIH HHS P20 CA 101955NCI NIH HHS P20 CA101955NCI NIH HHS R01 CA 083821NCI NIH HHS R01 CA083821NCI NIH HHS R01 CA094084NCI NIH HHS R01 CA 111569NCI NIH HHS R01 CA111569NCI NIH HHS R01 CA 94084NIDDK NIH HHS R01 DK 063615NIDDK NIH HHS R01 DK063615
6 · The paper itself

Abstract

The study of adenovirus could greatly benefit from diverse methods of virus detection. Recently, it has been demonstrated that carboxy-terminal EGFP fusions of adenovirus core proteins Mu, V, and VII properly localize to the nucleus and display novel function in the cell. Based on these observations, we hypothesized that the core proteins may serve as targets for labeling the adenovirus core with fluorescent proteins. To this end, we constructed various chimeric expression vectors with fusion core genes (Mu-EGFP, V-EGFP, preVII-EGFP, and matVII-EGFP) while maintaining expression of the native proteins. Expression of the fusion core proteins was suboptimal using E1 expression vectors with both conventional CMV and modified (with adenovirus tripartite leader sequence) CMV5 promoters, resulting in non-labeled viral particles. However, robust expression equivalent to the native protein was observed when the fusion genes were placed in the deleted E3 region. The efficient Ad-wt-E3-V-EGFP and Ad-wt-E3-preVII-EGFP expression vectors were labeled allowing visualization of purified virus and tracking of the viral core during early infection. The vectors maintained their viral function, including viral DNA replication, viral DNA encapsidation, cytopathic effect, and thermostability. Core labeling offers a means to track the adenovirus core in vector targeting studies as well as basic adenovirus virology.

Indexed as

AdenoviridaeAnimalsCell LineCricetinaeGene ExpressionGreen Fluorescent ProteinsHumansRecombinant ProteinsStaining and LabelingViral Core Proteinsenhanced green fluorescent proteinGreen Fluorescent ProteinsRecombinant ProteinsViral Core Proteins

Identifiers

PMID16678874
PMCPMC1781517
OpenAlexW2093724103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.